Biogen Inc. (BIIB)
NASDAQ·Healthcare·Drug Manufacturers - General
$182.64
+1.09%
Mkt Cap $26.91B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 6, 2026 | $2.20B | $2.28B | +3.48% | $1.63 | $1.99 | +22.09% | — | — |
| Q4 2025 Oct 30, 2025 | $2.34B | $2.45B | +4.91% | $3.88 | $4.81 | +23.97% | — | — |
| Q3 2025 Jul 31, 2025 | $2.33B | $2.65B | +13.63% | $3.90 | $5.47 | +40.26% | — | — |
| Q2 2025 May 1, 2025 | $2.23B | $2.43B | +8.81% | $2.90 | $3.02 | +4.14% | — | — |
| Q1 2025 Feb 12, 2025 | $2.41B | $2.45B | +1.93% | $3.43 | $3.44 | +0.29% | — | — |
| Q4 2024 Oct 30, 2024 | $2.43B | $2.47B | +1.29% | $3.77 | $4.08 | +8.22% | — | — |
| Q3 2024 Aug 1, 2024 | $2.39B | $2.35B | -1.65% | $4.07 | $5.28 | +29.73% | — | — |
| Q2 2024 Apr 24, 2024 | $2.31B | $2.20B | -4.71% | $3.47 | $3.67 | +5.76% | — | — |
| Q1 2024 Feb 13, 2024 | $2.47B | $2.39B | -3.19% | $3.16 | $2.95 | -6.65% | — | — |
| Q4 2023 Nov 8, 2023 | $2.39B | $2.53B | +5.88% | $3.99 | $4.36 | +9.27% | — | — |
| Q3 2023 Jul 25, 2023 | $2.37B | $2.46B | +3.66% | $3.77 | $4.02 | +6.63% | — | — |
| Q2 2023 Apr 25, 2023 | $2.34B | $2.46B | +5.17% | $3.28 | $3.40 | +3.66% | — | — |
| Q1 2023 Feb 15, 2023 | $2.45B | $2.54B | +4.04% | $3.48 | $4.05 | +16.38% | — | — |
| Q4 2022 Oct 25, 2022 | $2.47B | $2.51B | +1.60% | $4.13 | $4.77 | +15.50% | — | — |
| Q3 2022 Jul 20, 2022 | $2.47B | $2.59B | +4.66% | $4.06 | $5.25 | +29.31% | — | — |
| Q2 2022 May 3, 2022 | $2.50B | $2.53B | +1.28% | $4.41 | $3.62 | -17.91% | — | — |
| Q1 2022 Feb 3, 2022 | $2.62B | $2.73B | +4.34% | $3.32 | $3.39 | +2.11% | — | — |
| Q4 2021 Oct 20, 2021 | $2.67B | $2.78B | +4.07% | $4.15 | $4.77 | +14.94% | — | — |
| Q3 2021 Jul 22, 2021 | $2.68B | $2.77B | +3.73% | $4.57 | $5.68 | +24.29% | — | — |
| Q2 2021 Apr 22, 2021 | $2.67B | $2.69B | +1.09% | $5.06 | $5.34 | +5.53% | — | — |